Compare American Electric Power Company Inc (AEP) vs Cronos Group Inc (CRON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Electric Power Company Inc vs Cronos Group Inc — how do they compare? American Electric Power Company Inc trades at $123.61 (market cap $66.87B), while Cronos Group Inc trades at $3.08 (market cap $1.11B). The key difference: American Electric Power Company Inc is far larger — about 60.2× Cronos Group Inc's market cap, and American Electric Power Company Inc pays a 3.09% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| AEP | CRON | |
|---|---|---|
Market Cap | $66.87B | $1.11B |
Sector | Utilities | Health |
52-Week High | $138.69 | $3.27 |
52-Week Low | $106.44 | $2.30 |
Enterprise Value | $119.77B | $310.67M |
Dividend Yield | 3.09% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Electric Power Company Inc
American Electric Power is one of the largest regulated utilities in the United States, providing electricity generation, transmission, and distribution to more than 5 million customers in 11 states. About 43% of AEP's of capacity is coal, with the remainder from a mix of natural gas (27%), renewable energy and hydro (19%), nuclear (7%), and demand response (4%). Vertically integrated utilities, transmission and distribution, and generation and marketing support earnings.
Read more on AEP →About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →
